Professional Documents
Culture Documents
Image of Beximco
Pharmaceuticals Ltd in the
Pharmaceuticals
Prepared By: Industry
Md. Farhan Faruqui
Roll-54, Batch- 37 E
MBA Program, IBA
INTRODUCTION
Methodology
Secondary data
Study reports on Bangladesh pharmaceuticals market
Market research done by BPL
Reference books on the pharmaceuticals marketing
Questionnaire survey
Both executive and questionnaire method used
Survey conducted through questionnaire
interview
Limitations
Only the doctors were chosen as the respondents
Field force biases
Organizational Part
Beximco Group
Corporate Scenario
Largest business conglomerate of private sector in
Bangladesh
Rational Appeals :
1. Product Related Appeals
Economy
Degree of Innovation
Differentiation/ Position
Packaging
Dosage Form/ Taste
2. Physician Related Appeals
Peer/ Specialist Approval
Pharmaceutical Committee Approval
Therapeutic Aid in Practice
25
20
% of Rating
15
10
0
Beximco Square ACI Ops o nin ACME Aventis Others
20
15
10
0
Beximco Square ACI Ops o nin ACME Aventis Others
13 % 16 %
20%
23%
6%
4% 18 %
Company % of Rating
Beximco 22
Square 23
ACI 16
Opsonin 05
ACME 06
Aventis 17
Others 11
Pricing
Not much price differentiation
Moreover, price is not a very important factor
Reasonable Pricing
10%
3% 1%
6%
40%
7%
33%
Beximco Square ACI Opsonin
ACME Aventis Others
Availibility of Product
30
25
20
% of Rating
15
10
0
Beximco Square ACI Ops onin ACME Aventis Others
Medical Representatives
Must be both knowledgeable and able to provide
prompt service
Service of Medical Representatives Knowledge of Medical Representatives
5% 18%
20% 2 5%
25%
9%
20%
12 % 22%
6% 6% 10%
10% 12%
Beximco Square ACI Opsonin
Beximco Square ACI Opsonin
ACME Aventis Others
ACME Aventis Others
Medical Newsletters
22%
25%
9% 4% 5%
Beximco Square ACI Opsonin
ACME Aventis Others
Printed Promotional Materials
16% 18%
26% 21%
10% 4% 5%
30
25
20
15
10
5
0
Beximco Sq uare ACI Op s o nin ACM E Avent is Others
10 %
25%
15 %
19 % 22%
5% 4%
35
30
25
% of Rating
20
15
10
0
B e ximc o S quare ACI Ops o nin ACME Ave ntis Othe rs
Reasons for preferance
30
25
20
% o f R atin g
15
10